title: Gallium-68 somatostatin receptor PET/CT: is it time to replace (111)Indium DTPA octreotide for patients with neuroendocrine tumors?
authors.forename: Kjell
authors.initials: K
authors.lastname: Öberg
mesh_terms: D004701:Endocrine Gland Neoplasms / Q000000981:diagnostic imaging*; D005710:Gallium Radioisotopes; D006801:Humans; D008495:Medical Oncology / Q000379:methods / Q000639:trends*; D064847:Multimodal Imaging / Q000379:methods*; D018358:Neuroendocrine Tumors / Q000000981:diagnostic imaging*; D015282:Octreotide / Q000031:analogs & derivatives*; D004369:Pentetic Acid; D049268:Positron-Emission Tomography; D011379:Prognosis; D012372:ROC Curve; D017481:Receptors, Somatostatin / Q000737:chemistry / Q000378:metabolism*; D013997:Time Factors; D014057:Tomography, X-Ray Computed
chemical_list: D005710:Gallium Radioisotopes; D017481:Receptors, Somatostatin; C094279:indium-111-octreotide; D004369:Pentetic Acid; D015282:Octreotide